Cerebral Ischemia and Angiogenesis
Journal:
Current Neurovascular Research
Volume:
3
Page:
119-129
Author(s):
Takeshi Hayashi, Kentaro Deguchi, Shoko Nagotani, Hanzhe Zhang, Yoshihide Sehara, Atsushi Tsuchiya and Koji Abe
Neurovascular Mechanisms of Hypertension in Pregnancy
Journal:
Current Neurovascular Research
Volume:
3
Page:
131-148
Author(s):
Amanda K. Stennett and Raouf A. Khalil
Autoantibodies Associated with Psychiatric Disorders
Journal:
Current Neurovascular Research
Volume:
3
Page:
149-157
Author(s):
Paola Margutti, Federica Delunardo and Elena Ortona
Electron Paramagnetic Resonance (EPR) Spectroscopy: A Versatile and Powerful Tool in Pharmaceutical and Biomedical Analysis
Journal:
Current Pharmaceutical Analysis
Volume:
2
Page:
141-159
Author(s):
Marina Carini, Giancarlo Aldini, Marica Orioli and Roberto M. Facino
Effects of Statins on Bone Markers, Bone Mineral Density and Fractures. Possible Role in Osteoporosis Treatment
Journal:
Current Pharmaceutical Analysis
Volume:
2
Page:
161-168
Author(s):
Jose L. Perez-Castrillon, Laura Abad, Gema Vega, Alberto Sanz-Cantalapiedra, Santiago Sanchez, Gonzalo Hernandez and Antonio Duenas
Recent Advances in the Analyses of Carotenoids and Their Role in Human Health
Journal:
Current Pharmaceutical Analysis
Volume:
2
Page:
195-204
Author(s):
E-S. M. Abdel-Aal and M. H. Akhtar
Editorial [Hot Topic: Cyclooxygenase-2 Inhibitors and Cancer (Guest Editor: J.-P. Henichart)]
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
185-185
Author(s):
Jean-Pierre Henichart
The Potential and Rationale for COX-2 Inhibitors in Lung Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
6
Page:
209-220
Author(s):
Kostyantyn Krysan, Karen L. Reckamp, Sherven Sharma and Steven M. Dubinett
Transcription Factors in Asthma: Are Transcription Factors a New Target for Asthma Therapy?
Journal:
Current Drug Targets
Volume:
7
Page:
589-595
Author(s):
M. Roth and J. L. Black
Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?
Journal:
Current Drug Targets
Volume:
7
Page:
629-637
Author(s):
B. A. De Campo and P. J. Henry